-
1
-
-
44349193400
-
Stepping out of the flow: Capillary extravasation in cancer metastasis
-
DOI 10.1007/s10585-007-9098-2
-
Miles FL, Pruitt FL, van Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008;25:305-24. (Pubitemid 351748980)
-
(2008)
Clinical and Experimental Metastasis
, vol.25
, Issue.4
, pp. 305-324
-
-
Miles, F.L.1
Pruitt, F.L.2
Van Golen, K.L.3
Cooper, C.R.4
-
2
-
-
36148941318
-
Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway
-
DOI 10.1007/s10555-007-9095-6, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler
-
Nakahara S, Raz A. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway. Cancer Metastasis Rev 2007;26:605-10. (Pubitemid 350115124)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.3-4
, pp. 605-610
-
-
Nakahara, S.1
Raz, A.2
-
3
-
-
0032714092
-
Secretion of the galectin family of mammalian carbohydrate-binding proteins
-
Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999;1473:172-85.
-
(1999)
Biochim Biophys Acta
, vol.1473
, pp. 172-185
-
-
Hughes, R.C.1
-
4
-
-
18044396712
-
On the role of galectin-3 in cancer apoptosis
-
DOI 10.1007/s10495-005-0801-y
-
Nakahara S, Oka N, Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005;10:267-75. (Pubitemid 40603482)
-
(2005)
Apoptosis
, vol.10
, Issue.2
, pp. 267-275
-
-
Nakahara, S.1
Oka, N.2
Raz, A.3
-
5
-
-
79955481307
-
The role of galectins in colorectal cancer progression
-
Barrow H, Rhodes JM, Yu L-G. The role of galectins in colorectal cancer progression. Int J Cancer 2011;129:1-8.
-
(2011)
Int J Cancer
, vol.129
, pp. 1-8
-
-
Barrow, H.1
Rhodes, J.M.2
Yu, L.-G.3
-
7
-
-
1542373600
-
Galectin-3 and metastasis
-
DOI 10.1023/B:GLYC.0000014084.01324.15
-
Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glycoconj J 2004;19:543-9. (Pubitemid 38316528)
-
(2002)
Glycoconjugate Journal
, vol.19
, Issue.7-9
, pp. 543-549
-
-
Takenaka, Y.1
Fukumori, T.2
Raz, A.3
-
8
-
-
11144241063
-
Galectins as modulators of tumour progression
-
DOI 10.1038/nrc1527
-
Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29-41. (Pubitemid 40052323)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.1
, pp. 29-41
-
-
Liu, F.-T.1
Rabinovich, G.A.2
-
9
-
-
0034101698
-
Concentrations of galectin-3 in the sera of normal controls and cancer patients
-
Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 2000;6:1389-93. (Pubitemid 30226225)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.4
, pp. 1389-1393
-
-
Iurisci, I.1
Tinari, N.2
Natoli, C.3
Angelucci, D.4
Cianchetti, E.5
Iacobelli, S.6
-
10
-
-
43149123081
-
Serum level of galectin-3 in human bladder cancer
-
DOI 10.2152/jmi.55.127
-
Sakaki M, Oka N, Nakanishi R, Yamaguchi K, Fukumori T, Kanayama HO. Serum level of galectin-3 in human bladder cancer. J Med Invest 2008;55:127-32. (Pubitemid 351643603)
-
(2008)
Journal of Medical Investigation
, vol.55
, Issue.1-2
, pp. 127-132
-
-
Sakaki, M.1
Oka, N.2
Nakanishi, R.3
Yamaguchi, K.4
Fukumori, T.5
Kanayama, H.-O.6
-
11
-
-
37049015985
-
The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
-
DOI 10.1016/j.oraloncology.2006.12.014, PII S1368837507000140
-
Saussez S, Lorfevre F, Lequeux T, Laurent G, Chantrain G, Vertongen F, et al. The determination of the levels of circulating galectin-1 and -3 inHNSCCpatients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 2008;44:86-93. (Pubitemid 350251284)
-
(2008)
Oral Oncology
, vol.44
, Issue.1
, pp. 86-93
-
-
Saussez, S.1
Lorfevre, F.2
Lequeux, T.3
Laurent, G.4
Chantrain, G.5
Vertongen, F.6
Toubeau, G.7
Decaestecker, C.8
Kiss, R.9
-
12
-
-
73349088135
-
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
-
Vereecken P, Awada A, Suciu S, Castro G, Morandini R, Litynska A, et al. Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res 2009;19:316-20.
-
(2009)
Melanoma Res
, vol.19
, pp. 316-320
-
-
Vereecken, P.1
Awada, A.2
Suciu, S.3
Castro, G.4
Morandini, R.5
Litynska, A.6
-
13
-
-
33646091536
-
High serum galectin-3 in advanced melanoma: Preliminary results
-
Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, et al. High serum galectin-3 in advanced melanoma: preliminary results. Clin Exp Dermatol 2006;31:105-9.
-
(2006)
Clin Exp Dermatol
, vol.31
, pp. 105-109
-
-
Vereecken, P.1
Zouaoui Boudjeltia, K.2
Debray, C.3
Awada, A.4
Legssyer, I.5
Sales, F.6
-
14
-
-
79955463679
-
Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis
-
Yu LG. Circulating galectin-3 in the bloodstream: an emerging promoter of cancer metastasis. World J Gastrointest Oncol 2010;2: 177-80.
-
(2010)
World J Gastrointest Oncol
, vol.2
, pp. 177-180
-
-
Yu, L.G.1
-
15
-
-
70149097554
-
Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface
-
Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, Rhodes JM, et al. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res 2009;69:6799-806.
-
(2009)
Cancer Res
, vol.69
, pp. 6799-6806
-
-
Zhao, Q.1
Guo, X.2
Nash, G.B.3
Stone, P.C.4
Hilkens, J.5
Rhodes, J.M.6
-
16
-
-
33846964873
-
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion
-
DOI 10.1074/jbc.M606862200
-
Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007;282:773-81. (Pubitemid 47076627)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.1
, pp. 773-781
-
-
Yu, L.-G.1
Andrews, N.2
Zhao, Q.3
McKean, D.4
Williams, J.F.5
Connor, L.J.6
Gerasimenko, O.V.7
Hilkens, J.8
Hirabayashi, J.9
Kasai, K.10
Rhodes, J.M.11
-
17
-
-
77953627018
-
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
-
Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer 2010;9:154.
-
(2010)
Mol Cancer
, vol.9
, pp. 154
-
-
Zhao, Q.1
Barclay, M.2
Hilkens, J.3
Guo, X.4
Barrow, H.5
Rhodes, J.M.6
-
18
-
-
78049310747
-
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
-
Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E, et al. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett 2010;299:95-110.
-
(2010)
Cancer Lett
, vol.299
, pp. 95-110
-
-
Stannard, K.A.1
Collins, P.M.2
Ito, K.3
Sullivan, E.M.4
Scott, S.A.5
Gabutero, E.6
-
19
-
-
33144460217
-
Galectin-1: A link between tumor hypoxia and tumor immune privilege
-
DOI 10.1200/JCO.2005.02.0206
-
Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 2005;23:8932-41. (Pubitemid 46211478)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.35
, pp. 8932-8941
-
-
Le, Q.-T.1
Shi, G.2
Cao, H.3
Nelson, D.W.4
Wang, Y.5
Chen, E.Y.6
Zhao, S.7
Kong, C.8
Richardson, D.9
O'Byrne, K.J.10
Giaccia, A.J.11
Koong, A.C.12
-
20
-
-
1642381066
-
Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate
-
DOI 10.1016/j.biolcel.2003.12.005, PII S024849000400005X
-
Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, et al. Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 2004;96:145-51. (Pubitemid 38391197)
-
(2004)
Biology of the Cell
, vol.96
, Issue.2
, pp. 145-151
-
-
Leteurtre, E.1
Gouyer, V.2
Rousseau, K.3
Moreau, O.4
Barbat, A.5
Swallow, D.6
Huet, G.7
Lesuffleur, T.8
-
21
-
-
0029937975
-
A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1
-
Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996;7:565-77. (Pubitemid 26112564)
-
(1996)
Molecular Biology of the Cell
, vol.7
, Issue.4
, pp. 565-577
-
-
Wesseling, J.1
Van Der, V.S.W.2
Hilkens, J.3
-
22
-
-
0030670516
-
Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 N-acetyl- galactosamine)
-
Yu LG, Jansson B, Fernig DG, Milton JD, Smith JA, Gerasimenko OV, et al. Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 Nacetyl-galactosamine). Int J Cancer 1997;73:424-31. (Pubitemid 27508906)
-
(1997)
International Journal of Cancer
, vol.73
, Issue.3
, pp. 424-431
-
-
Yu, L.-G.1
Jansson, B.2
Fernig, D.G.3
Milton, J.D.4
Smith, J.A.5
Gerasimenko, O.V.6
Jones, M.7
Rhodes, J.M.8
-
23
-
-
76749087478
-
Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes
-
Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 2010;70: 1306-13.
-
(2010)
Cancer Res
, vol.70
, pp. 1306-1313
-
-
Wandall, H.H.1
Blixt, O.2
Tarp, M.A.3
Pedersen, J.W.4
Bennett, E.P.5
Mandel, U.6
-
24
-
-
77957353124
-
A high-throughput O-glycopeptide discovery platform for seromic profiling
-
Blixt O, Clo E, Nudelman AS, Sorensen KK, Clausen T, Wandall HH, et al. A high-throughput O-glycopeptide discovery platform for seromic profiling. J Proteome Res 2010;9:5250-61.
-
(2010)
J Proteome Res
, vol.9
, pp. 5250-5261
-
-
Blixt, O.1
Clo, E.2
Nudelman, A.S.3
Sorensen, K.K.4
Clausen, T.5
Wandall, H.H.6
-
26
-
-
79959604351
-
Identification of galectins as novel regulators of platelet signaling and function
-
Romaniuk MA, Negrotto S, Campetella O, Rabinovich GA, Schattner M. Identification of galectins as novel regulators of platelet signaling and function. IUBMB Life 2011;63:521-7.
-
(2011)
IUBMB Life
, vol.63
, pp. 521-527
-
-
Romaniuk, M.A.1
Negrotto, S.2
Campetella, O.3
Rabinovich, G.A.4
Schattner, M.5
-
27
-
-
0025812569
-
Structural characterization of neutral oligosaccharides with blood-group A and H activity isolated from bovine submaxillary mucin
-
Savage AV, D'Arcy SM, Donoghue CM. Structural characterization of neutral oligosaccharides with blood-group A and H activity isolated from bovine submaxillary mucin. Biochem J 1991;279: 95-103.
-
(1991)
Biochem J
, vol.279
, pp. 95-103
-
-
Savage, A.V.1
D'Arcy, S.M.2
Donoghue, C.M.3
-
28
-
-
79953043430
-
Clinical significance of circulating galectins as colorectal cancer markers
-
Watanabe M, Takemasa I, Kaneko N, Yokoyama Y, Matsuo E, Iwasa S, et al. Clinical significance of circulating galectins as colorectal cancer markers. Oncol Rep 2011;25:1217-26.
-
(2011)
Oncol Rep
, vol.25
, pp. 1217-1226
-
-
Watanabe, M.1
Takemasa, I.2
Kaneko, N.3
Yokoyama, Y.4
Matsuo, E.5
Iwasa, S.6
-
29
-
-
0036175965
-
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor
-
DOI 10.1136/gut.50.3.392
-
Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 2002;50:392-401. (Pubitemid 34161058)
-
(2002)
Gut
, vol.50
, Issue.3
, pp. 392-401
-
-
Nagy, N.1
Bronckart, Y.2
Camby, I.3
Legendre, H.4
Lahm, H.5
Kaltner, H.6
Hadari, Y.7
Van Ham, P.8
Yeaton, P.9
Pector, J.-C.10
Zick, Y.11
Salmon, I.12
Danguy, A.13
Kiss, R.14
Gabius, H.-J.15
-
30
-
-
0030744362
-
Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer
-
Rechreche H, Mallo GV, Montalto G, Dagorn JC, Iovanna JL. Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. Eur J Biochem 1997;248:225-30. (Pubitemid 27356992)
-
(1997)
European Journal of Biochemistry
, vol.248
, Issue.1
, pp. 225-230
-
-
Rechreche, H.1
Mallo, G.V.2
Montalto, G.3
Dagorn, J.-C.4
Iovanna, J.L.5
-
31
-
-
78649334474
-
Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors
-
Isic T, Savin S, Cvejic D, Marecko I, Tatic S, Havelka M, et al. Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors. J Cancer Res Clin Oncol 2010;136:1805-12.
-
(2010)
J Cancer Res Clin Oncol
, vol.136
, pp. 1805-1812
-
-
Isic, T.1
Savin, S.2
Cvejic, D.3
Marecko, I.4
Tatic, S.5
Havelka, M.6
-
32
-
-
0030828689
-
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression
-
Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT, et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997;113:1906-15. (Pubitemid 27512149)
-
(1997)
Gastroenterology
, vol.113
, Issue.6
, pp. 1906-1915
-
-
Sanjuan, X.1
Fernandez, P.L.2
Castells, A.3
Castronovo, V.4
Van Den, B.F.5
Liu, F.-T.6
Cardesa, A.7
Campo, E.8
-
33
-
-
0027482681
-
Regulation of the expression of galactoside-binding lectin during human monocytic differentiation
-
Nangia-Makker P, Ochieng J, Christman JK, Raz A. Regulation of the expression of galactoside-binding lectin during human monocytic differentiation. Cancer Res 1993;53:5033-7. (Pubitemid 23326205)
-
(1993)
Cancer Research
, vol.53
, Issue.20
, pp. 5033-5037
-
-
Nangia-Makker, P.1
Ochieng, J.2
Christman, J.K.3
Raz, A.4
-
34
-
-
0035067004
-
Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes
-
Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a beta-galactoside- binding protein in activated T lymphocytes. J Leukoc Biol 2001;69:555-64. (Pubitemid 32294840)
-
(2001)
Journal of Leukocyte Biology
, vol.69
, Issue.4
, pp. 555-564
-
-
Joo, H.-G.1
Goedegebuure, P.S.2
Sadanaga, N.3
Nagoshi, M.4
Von Bernstorff, W.5
Eberlein, T.J.6
-
35
-
-
70349456528
-
Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells
-
van Stijn CM, van den Broek M, van de Weerd R, Visser M, Tasdelen I, Tefsen B, et al. Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells. Mol Immunol 2009;46: 3292-9.
-
(2009)
Mol Immunol
, vol.46
, pp. 3292-3299
-
-
Van Stijn, C.M.1
Van Den Broek, M.2
Van De Weerd, R.3
Visser, M.4
Tasdelen, I.5
Tefsen, B.6
-
36
-
-
18144425556
-
IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1 > 3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand
-
DOI 10.1016/j.ijbiomac.2005.03.004
-
Sangeetha SR, Appukuttan PS. IgA1 is the premier serum glycoprotein recognizedbyhumangalectin-1 sinceTantigen (Galbeta1->3GalNAc-) is far superior tonon-repeating N-acetyl lactosamine as ligand. Int J Biol Macromol 2005;35:269-76. (Pubitemid 40615989)
-
(2005)
International Journal of Biological Macromolecules
, vol.35
, Issue.5
, pp. 269-276
-
-
Sangeetha, S.R.1
Appukuttan, P.S.2
-
37
-
-
4444360281
-
A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer
-
DOI 10.1053/j.gastro.2004.06.016, PII S0016508504010388
-
Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, et al. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology 2004; 127:741-8. (Pubitemid 39208407)
-
(2004)
Gastroenterology
, vol.127
, Issue.3
, pp. 741-748
-
-
Bresalier, R.S.1
Byrd, J.C.2
Tessler, D.3
Lebel, J.4
Koomen, J.5
Hawke, D.6
Half, E.7
Liu, K.-F.8
Mazurek, N.9
-
38
-
-
77249143983
-
Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients
-
Iacovazzi PA, Notarnicola M, Caruso MG, Guerra V, Frisullo S, Altomare DF. Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients. Immunopharmacol Immunotoxicol 2010; 32:160-4.
-
(2010)
Immunopharmacol Immunotoxicol
, vol.32
, pp. 160-164
-
-
Iacovazzi, P.A.1
Notarnicola, M.2
Caruso, M.G.3
Guerra, V.4
Frisullo, S.5
Altomare, D.F.6
-
39
-
-
42449153703
-
Different affinity of galectins for human serum glycoproteins: Galectin-3 binds many protease inhibitors and acute phase proteins
-
DOI 10.1093/glycob/cwn015
-
Cederfur C, Salomonsson E, Nilsson J, Halim A, Oberg CT, Larson G, et al. Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 2008;18:384-94. (Pubitemid 351560539)
-
(2008)
Glycobiology
, vol.18
, Issue.5
, pp. 384-394
-
-
Cederfur, C.1
Salomonsson, E.2
Nilsson, J.3
Halim, A.4
Oberg, C.T.5
Larson, G.6
Nilsson, U.J.7
Leffler, H.8
-
40
-
-
17344392248
-
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
-
von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, Snijdewint FG, Kok A, Van Kamp GJ, et al. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 2000;18:574-83. (Pubitemid 30078538)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.3
, pp. 574-583
-
-
Von Mensdorff-Pouilly, S.1
Verstraeten, A.A.2
Kenemans, P.3
Snijdewint, F.G.M.4
Kok, A.5
Van Kamp, G.J.6
Paul, M.A.7
Van Diest, P.J.8
Meijer, S.9
Hilgers, J.10
-
41
-
-
34247232152
-
Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: Relation to survival
-
DOI 10.1080/02841860601055441, PII 777298241
-
Kurtenkov O, Klaamas K, Mensdorff-Pouilly S, Miljukhina L, Shljapnikova L, Chuzmarov V. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival. Acta Oncol 2007;46:316-23. (Pubitemid 46625032)
-
(2007)
Acta Oncologica
, vol.46
, Issue.3
, pp. 316-323
-
-
Kurtenkov, O.1
Klaamas, K.2
Mensdorff-Pouilly, S.3
Miljukhina, L.4
Shljapnikova, L.5
Chuzmarov, V.6
-
42
-
-
70349265219
-
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer
-
Silk AW, Schoen RE, Potter DM, Finn OJ. Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. Mol Immunol 2009;47:52-6.
-
(2009)
Mol Immunol
, vol.47
, pp. 52-56
-
-
Silk, A.W.1
Schoen, R.E.2
Potter, D.M.3
Finn, O.J.4
-
45
-
-
4644305974
-
Human galectin-2: Novel inducer of T cell apoptosis with distinct profile of caspase activation
-
Sturm A, Lensch M, Andre S, Kaltner H, Wiedenmann B, Rosewicz S, et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004;173:3825-37. (Pubitemid 39280745)
-
(2004)
Journal of Immunology
, vol.173
, Issue.6
, pp. 3825-3837
-
-
Sturm, A.1
Lensch, M.2
Andre, S.3
Kaltner, H.4
Wiedenmann, B.5
Rosewicz, S.6
Dignass, A.U.7
Gabius, H.-J.8
-
46
-
-
46949103440
-
Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion
-
Stowell SR, Qian Y, Karmakar S, Koyama NS, Dias-Baruffi M, Leffler H, et al. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 2008;180: 3091-102.
-
(2008)
J Immunol
, vol.180
, pp. 3091-3102
-
-
Stowell, S.R.1
Qian, Y.2
Karmakar, S.3
Koyama, N.S.4
Dias-Baruffi, M.5
Leffler, H.6
-
47
-
-
61349103843
-
The immunological potential of galectin-1 and -3
-
Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT. The immunological potential of galectin-1 and -3. Autoimmun Rev 2009;8:360-3.
-
(2009)
Autoimmun Rev
, vol.8
, pp. 360-363
-
-
Dhirapong, A.1
Lleo, A.2
Leung, P.3
Gershwin, M.E.4
Liu, F.T.5
-
48
-
-
24944450621
-
Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants
-
DOI 10.1021/bi051144z
-
Dam TK, Gabius HJ, Andre S, Kaltner H, Lensch M, Brewer CF. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 2005;44:12564-71. (Pubitemid 41324347)
-
(2005)
Biochemistry
, vol.44
, Issue.37
, pp. 12564-12571
-
-
Dam, T.K.1
Gabius, H.-J.2
Andre, S.3
Kaltner, H.4
Lensch, M.5
Brewer, C.F.6
|